Research activities initiated at Entomology lab in St. Petersburg
Univ.

Polyfensin' isolated from insect immune system
Preclinical trial of Polyfensin undertaken

Alloferon isolated and its structure determined (CNRS)

Alloferon Co. founded in Russia
Patents for Polyfensin and Alloferon filed in United States,
European Union, Japan, Russia and Korea

EntoPharm incorporated.
Company subsequently raised US$ 2.5 million
Collaborative research with Seoul National University immunology
lab launched.
Phase I clinical trial of Alloferon begun.

Korean marketing right to Alloferon licensed to Pacific Corp.
Synthesization of S2, a potential anti-cancer drug candidate.

 

Successful completion of phase II clinical trial of Alloferon for
chronic herpes.
Published a paper on Alloferon in the Proceedings of the National
Academy of Sciences
USA.